$ITRI

Itron (NASDAQ: ITRI) officer plans $24K sale from restricted stock vesting

Itron (ITRI) officer Donald L. Reeves III plans to sell 247 shares, valued at $24,420.89, from restricted stock vesting. Reeves has sold 1,453 shares in the past three months, totaling $100,274.19. The sales are part of a Form 144 filing, indicating planned stock sales.

Original reporting
Published Aug 21, 2026, 2:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ITRI
Neutral
high confidence
Mentioned
$ITRI
Relevance
5/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ITRINeutralLow
01

Why it matters

The disclosed sale adds modest supply; no immediate catalyst beyond the filing.

02

Market read

Limited relevance; typical for routine insider sales.

03

What to watch

Potential cumulative effect if multiple insiders sell in short period.

Relevance 5/10Novelty 5/10Timing: August 21 2026 filing

Background

Form 144 is required for insiders planning to sell restricted shares, providing transparency on upcoming supply.

Company-level read

Ticker impact

$ITRINeutralHigh confidence
Context

Form 144 filing shows officer Donald L. Reeves III plans to sell 247 shares (~$24.4K) from restricted stock vesting.

Expected impact

Minimal downward pressure, likely within normal trading range.

Evidence & confidence

The sale size is small relative to market cap and typical daily volume, so impact is limited.

Market effects

None

None

None

Counterpoint

Even small insider sales can signal lack of confidence; monitor for further disposals.

Key entities

  • Donald L. Reeves III

    Officer of Itron Inc. planning the share sale.

Related articles

$VIAVMed

Inspection Instruments Stocks Q2 Earnings Review: Keysight (NYSE:KEYS) Shines

Viavi Solutions (down 10.9%) had the fastest revenue growth among inspection instruments stocks, while Badger Meter (NYSE:BMI, down 9.3%) reported a 6.6% revenue decline. Itron (NASDAQ:ITRI, up 12.2%) missed revenue estimates but exceeded EBITDA and EPS guidance. Teledyne (NYSE:TDY, down 3.7%) reported a 9.8% revenue increase, beating expectations. Market risks have shifted from AI to geopolitics and back to fundamentals.

$ITRIMedAI 8/10

Why Shares of Itron Stock Jumped 17.4% This Week

Itron shares rose about 17% this week after the company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Itron posted non-GAAP EPS of $1.59 versus $1.29 expected and cited demand for grid stability tied to AI infrastructure build-out. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMed

Why Shares of Itron Stock Jumped 17.4% This Week

Itron (NASDAQ: ITRI) shares rose about 17.4% this week, after the utility technology company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Non-GAAP EPS was $1.59 versus $1.29 expected. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMedAI 8/10

Itron Q2 Earnings Call Highlights

Itron (NASDAQ:ITRI) reported Q2 GAAP net income of $53M, or $1.19/diluted share, versus $68M a year earlier. Non-GAAP operating income rose 8% to $89M and adjusted EBITDA rose 8% to $97M. Q2 revenue by segment: Device Solutions $111M, Networked Solutions $339M, Outcomes $96M, Resiliency Solutions about $16M. Free cash flow was $81M. Backlog was $4.4B. Itron raised full-year non-GAAP EPS to $6.30-$6.50 and narrowed revenue to $2.37B-$2.41B.